JP2013519379A5 - - Google Patents

Download PDF

Info

Publication number
JP2013519379A5
JP2013519379A5 JP2012553038A JP2012553038A JP2013519379A5 JP 2013519379 A5 JP2013519379 A5 JP 2013519379A5 JP 2012553038 A JP2012553038 A JP 2012553038A JP 2012553038 A JP2012553038 A JP 2012553038A JP 2013519379 A5 JP2013519379 A5 JP 2013519379A5
Authority
JP
Japan
Prior art keywords
polypeptide
cell
seq
immunoglobulin
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012553038A
Other languages
English (en)
Japanese (ja)
Other versions
JP6034696B2 (ja
JP2013519379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/024554 external-priority patent/WO2011100566A2/en
Publication of JP2013519379A publication Critical patent/JP2013519379A/ja
Publication of JP2013519379A5 publication Critical patent/JP2013519379A5/ja
Application granted granted Critical
Publication of JP6034696B2 publication Critical patent/JP6034696B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012553038A 2010-02-12 2011-02-11 ポリペプチド発現細胞の同定及び単離の方法 Expired - Fee Related JP6034696B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30425110P 2010-02-12 2010-02-12
US61/304,251 2010-02-12
US201161437889P 2011-01-31 2011-01-31
US61/437,889 2011-01-31
PCT/US2011/024554 WO2011100566A2 (en) 2010-02-12 2011-02-11 Methods for identifying and isolating cells expressing a polypeptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016139165A Division JP2017014220A (ja) 2010-02-12 2016-07-14 ポリペプチド発現細胞の同定及び単離の方法

Publications (3)

Publication Number Publication Date
JP2013519379A JP2013519379A (ja) 2013-05-30
JP2013519379A5 true JP2013519379A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP6034696B2 JP6034696B2 (ja) 2016-11-30

Family

ID=44368462

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553038A Expired - Fee Related JP6034696B2 (ja) 2010-02-12 2011-02-11 ポリペプチド発現細胞の同定及び単離の方法
JP2016139165A Withdrawn JP2017014220A (ja) 2010-02-12 2016-07-14 ポリペプチド発現細胞の同定及び単離の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016139165A Withdrawn JP2017014220A (ja) 2010-02-12 2016-07-14 ポリペプチド発現細胞の同定及び単離の方法

Country Status (12)

Country Link
US (5) US8551715B2 (cg-RX-API-DMAC7.html)
EP (1) EP2534257B1 (cg-RX-API-DMAC7.html)
JP (2) JP6034696B2 (cg-RX-API-DMAC7.html)
KR (1) KR20120117931A (cg-RX-API-DMAC7.html)
CN (1) CN102844442B (cg-RX-API-DMAC7.html)
AU (1) AU2011215685B2 (cg-RX-API-DMAC7.html)
CA (1) CA2789446A1 (cg-RX-API-DMAC7.html)
IL (1) IL221349A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012009175A (cg-RX-API-DMAC7.html)
NZ (1) NZ601743A (cg-RX-API-DMAC7.html)
SG (2) SG10201503736XA (cg-RX-API-DMAC7.html)
WO (1) WO2011100566A2 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919092B2 (en) 2006-06-13 2011-04-05 Oncomed Pharmaceuticals, Inc. Antibodies to notch receptors
HRP20160082T1 (hr) 2006-09-29 2016-02-26 Oncomed Pharmaceuticals, Inc. Sastavi i postupci za dijagnosticiranje i lijeäśenje raka
WO2008091641A2 (en) 2007-01-24 2008-07-31 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
US9249423B2 (en) 2007-02-02 2016-02-02 Yale University Method of de-differentiating and re-differentiating somatic cells using RNA
WO2008097926A2 (en) * 2007-02-02 2008-08-14 Yale University Transient transfection with rna
US10155038B2 (en) 2007-02-02 2018-12-18 Yale University Cells prepared by transient transfection and methods of use thereof
CN102112490B (zh) 2008-07-08 2014-10-22 昂考梅德药品有限公司 Notch1受体结合剂和其使用方法
US9132189B2 (en) 2008-07-08 2015-09-15 Oncomed Pharmaceuticals, Inc. Notch1 binding agents and methods of use thereof
EP3485908B1 (en) 2009-10-16 2021-08-18 Mereo BioPharma 5, Inc. Therapeutic combination and use of dll4 antagonist antibodies and anti-hypertensive agents
KR20120117931A (ko) 2010-02-12 2012-10-24 온코메드 파마슈티칼스, 인크. 폴리펩타이드를 발현하는 세포를 확인 및 분리하는 방법
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
US9365846B2 (en) 2010-12-01 2016-06-14 Merck Sharp & Dohme Corp. Surface, anchored Fc-bait antibody display system
US10106598B2 (en) 2010-12-01 2018-10-23 Merck Sharp & Dohme Corp. Surface, anchored Fc-bait antibody display system
WO2013012747A1 (en) 2011-07-15 2013-01-24 Oncomed Pharmaceuticals, Inc. Rspo binding agents and uses thereof
TWI583699B (zh) 2011-09-23 2017-05-21 安可美德藥物股份有限公司 Vegf/dll4結合劑類及彼等之用途
MX2014014951A (es) 2012-06-06 2015-03-13 Oncomed Pharm Inc Agentes aglutinantes que modulan la trayectoria hippo y sus usos.
CN104854132A (zh) 2012-07-13 2015-08-19 昂考梅德药品有限公司 Rspo3结合剂及其用途
PL3489261T3 (pl) 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
WO2014062659A2 (en) * 2012-10-15 2014-04-24 Oncomed Pharmaceuticals, Inc. Methods of treating ocular diseases
US8921055B2 (en) * 2012-10-30 2014-12-30 Berkeley Lights, Inc. Detecting cells secreting a protein of interest
CA2889638A1 (en) 2012-10-31 2014-05-08 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a dll4 antagonist
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
AU2014249148B2 (en) * 2013-03-11 2020-04-02 Regeneron Pharmaceuticals, Inc. Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
GB201405845D0 (en) 2014-04-01 2014-05-14 Ucl Business Plc Signalling system
GB201407852D0 (en) 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
GB201415347D0 (en) * 2014-08-29 2014-10-15 Ucl Business Plc Signalling system
EP3212233B1 (en) 2014-10-31 2020-06-24 Oncomed Pharmaceuticals, Inc. Combination therapy for treatment of disease
CA2966988A1 (en) * 2014-11-06 2016-05-12 Children's Research Institute, Children's National Medical Center Immunotherapeutics for cancer and autoimmune diseases
CN107429253B (zh) 2014-12-05 2021-11-05 希望之城公司 Cs1靶向性嵌合抗原受体修饰的t细胞
TWI715587B (zh) 2015-05-28 2021-01-11 美商安可美德藥物股份有限公司 Tigit結合劑和彼之用途
US11339213B2 (en) 2015-09-23 2022-05-24 Mereo Biopharma 5, Inc. Methods and compositions for treatment of cancer
CA3019835A1 (en) 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy
KR20230047507A (ko) 2016-06-27 2023-04-07 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 암 치료 조합
MX2019006072A (es) 2016-11-30 2019-08-14 Oncomed Pharm Inc Metodos para tratamiento de cancer que comprenden agentes de enlace al inmunoreceptor de celulas t con dominios ige itim (tigit).
AU2018219226B2 (en) 2017-02-07 2024-12-19 Seattle Children's Hospital (dba Seattle Children's Research Institute) Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
CN110582288B (zh) 2017-02-28 2024-09-20 恩多塞特公司 用于car t细胞疗法的组合物和方法
JP7287940B2 (ja) 2017-03-24 2023-06-06 ランケナウ・インスティテュート・フォー・メディカル・リサーチ ハイブリドーマによって分泌されるモノクローナル免疫グロブリンの誘導性細胞外膜捕捉のための方法及び組成物
WO2019144095A1 (en) 2018-01-22 2019-07-25 Seattle Children's Hospital (dba Seattle Children's Research Institute) Methods of use for car t cells
AU2019218729B2 (en) 2018-02-06 2025-12-04 Seattle Children's Hospital (dba Seattle Children's Research Institute) Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors
JP7568224B2 (ja) 2018-02-23 2024-10-16 エンドサイト・インコーポレイテッド Car t細胞療法のための配列決定法
CN112930186A (zh) 2018-08-16 2021-06-08 纪念斯隆-凯特琳癌症中心 基于亮氨酸拉链的组合物和使用方法
CN112996819B (zh) * 2018-08-16 2025-11-04 纪念斯隆-凯特琳癌症中心 细胞分选系统及使用方法
CN112969476B (zh) * 2018-12-07 2024-06-14 江苏恒瑞医药股份有限公司 多特异性蛋白分子
CN109738506B (zh) * 2019-01-10 2021-02-26 青岛大学附属医院 一种成熟脂肪细胞中自噬相关蛋白乙酰化位点研究方法
WO2020210816A1 (en) * 2019-04-12 2020-10-15 Methodist Hospital Research Institute Therapeutic particles that enable antigen presenting cells to attack cancer cells
IL295063A (en) 2020-02-04 2022-09-01 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Chimeric antigen receptors (car) against dinitrophenol
JP2024531431A (ja) 2021-08-25 2024-08-29 イオンタス リミテッド 真核細胞で発現するタンパク質変異体のライブラリーの調製
EP4526351A2 (en) * 2022-05-16 2025-03-26 City of Hope Anti-cd84 antibodies and uses thereof
KR20250141200A (ko) * 2023-02-01 2025-09-26 알렌 인스티튜트 전압-게이팅 나트륨 채널 기능의 인테인 매개 재구성
WO2024251820A1 (en) 2023-06-06 2024-12-12 Iontas Limited Preparation of libraries of bispecific binders expressed in eukaryotic cells
CN122497524A (zh) * 2024-01-12 2026-07-31 索诺玛生物治疗公司 具有非典型跨膜结构域和/或铰链结构域的嵌合抗原受体

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
US7166423B1 (en) 1992-10-21 2007-01-23 Miltenyi Biotec Gmbh Direct selection of cells by secretion product
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US6121022A (en) 1995-04-14 2000-09-19 Genentech, Inc. Altered polypeptides with increased half-life
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US6828422B1 (en) 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
EP0937095A4 (en) * 1996-10-25 1999-12-22 Cell Genesys Inc TARGETED CYTOLYSIS OF CANCER CELLS
WO1998041613A1 (en) * 1997-03-14 1998-09-24 Otten Gillis R Targeted cytolysis of cancer cells
ES2513043T3 (es) * 1997-03-26 2014-10-24 Imperial Innovations Limited Proteína de fusión anticoagulante anclada a membrana de la célula
US5837994C1 (en) 1997-04-02 2001-10-16 Gentex Corp Control system to automatically dim vehicle head lamps
US7176179B1 (en) * 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
JP3614866B2 (ja) 1997-06-12 2005-01-26 リサーチ コーポレイション テクノロジーズ,インコーポレイティド 人工抗体ポリペプチド
US6180343B1 (en) 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides
US6197294B1 (en) * 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
DE19900635A1 (de) * 1999-01-11 2000-07-13 Deutsches Krebsforsch Selektion von monoklonalen Antikörpern
ATE482275T1 (de) 1999-07-02 2010-10-15 Morphosys Ag Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
US7498304B2 (en) * 2000-06-16 2009-03-03 Curis, Inc. Angiogenesis-modulating compositions and uses
US7094571B2 (en) 2000-10-27 2006-08-22 The Board Of Regents Of The University Of Texas System Combinatorial protein library screening by periplasmic expression
CN1306272C (zh) * 2000-11-17 2007-03-21 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的方法
ATE325865T1 (de) 2001-01-16 2006-06-15 Regeneron Pharma Isolierung von sezernierte proteine exprimierenden zellen
US20030171546A1 (en) * 2001-04-30 2003-09-11 City Of Hope Chimeric immunoreceptor useful in treating human cancers
WO2003106639A2 (en) 2002-06-14 2003-12-24 Dyax Corporation Recombination of nucleic acid library members
JP4748984B2 (ja) * 2002-06-16 2011-08-17 ダイアックス、コープ 核酸ライブラリーメンバーの組換え
EP1636561B1 (en) * 2002-07-15 2011-02-09 Board Of Regents, The University Of Texas System Combinatorial protein library screening by periplasmic expression
FR2849039B1 (fr) 2002-12-24 2010-10-01 Centre Nat Rech Scient Nouvelle proteine associee aux centrosomes et ses applications
EP1447413A3 (en) * 2003-02-14 2006-01-04 Research Association for Biotechnology Full-length human cDNA
US20070048740A1 (en) 2003-02-14 2007-03-01 Research Association For Biotechnology Full-length cDNA
US7479538B2 (en) * 2004-11-12 2009-01-20 The Zhabilov Trust Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV
AU2006304387A1 (en) * 2005-10-14 2007-04-26 Medimmune, Llc Cell display of antibody libraries
WO2007115230A2 (en) * 2006-03-30 2007-10-11 University Of Medicine And Dentistry Of New Jersey A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells
EP2068914A4 (en) * 2007-02-09 2011-07-20 Medimmune Llc PRESENTATION OF ANTIBODY BANK BY PLASMA MEMBRANES OF YEAST CELLS
US8067339B2 (en) 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
KR20120117931A (ko) 2010-02-12 2012-10-24 온코메드 파마슈티칼스, 인크. 폴리펩타이드를 발현하는 세포를 확인 및 분리하는 방법
US9365846B2 (en) * 2010-12-01 2016-06-14 Merck Sharp & Dohme Corp. Surface, anchored Fc-bait antibody display system

Similar Documents

Publication Publication Date Title
JP7150880B2 (ja) 抗-b7-h3抗体およびその用途
JP7287963B2 (ja) 抗tigit抗体並びに治療剤及び診断剤としてのその使用
KR101455447B1 (ko) Muc1* 항체
CN107880128B (zh) 一种抗cd19的全人源抗体或抗体片段及其方法和应用
CN112574307A (zh) 抗人Claudin18.2抗体及其应用
EP3999550A1 (en) Anti-dll3 chimeric antigen receptors and uses thereof
TW202332697A (zh) 細胞傷害誘導治療劑
KR20190044626A (ko) 항-cd19 항체에 대한 항-이디오타입 항체
CN109661235B (zh) 抗原结合分子及其使用的方法
CA2947157A1 (en) T cell-redirected antigen-binding molecule for cells having immunosuppression function
CA3117756A1 (en) Novel agonistic antibody molecules
JPWO2017086419A1 (ja) 液性免疫応答の増強方法
JP2017536412A (ja) T細胞再標的化ヘテロ二量体免疫グロブリン
CN104829727B (zh) 一种双特异性抗体cd19×cd3的构建及应用
JP2024153077A (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
TW202221042A (zh) Pd-1/vegf四價雙特異性抗體、其製備方法和用途
JP2025503573A (ja) 抗gprc5d抗体及びその応用
CA3117864A1 (en) Novel antagonistic anti tnfr2 antibody molecules
JP2024512957A (ja) Cd3に結合する多重特異性抗原結合タンパク質とその使用方法
CN113912731A (zh) 一种抗fgl1抗体及其应用
US20250000976A1 (en) Anti-bcma single domain antibodies and therapeutic constructs
JP2025504795A (ja) 抗体及びその用途
JP2025505650A (ja) 抗イディオタイプ抗体分子及びその使用
CN112794907A (zh) 一株全人源抗人huOX40单克隆抗体
CN113423720A (zh) CAR文库和scFv的制造方法